TY  - Journal article
AU  - Evan Doran
AU  - Hans Lofgren


PY  - 2013
T1  - Drug promotion in Australia: policy contestation and the tightening of regulation
PB  - Australian Review of Public Affairs


DO  - https://doi.org/APO-33429
UR  - https://apo.org.au/node/33429

AB  - While consumers have long been assumed to be in need of protection from drug promotion, it is now accepted that marketing to medical professionals should also be more closely controlled. Public health advocates have effectively highlighted the negative impact of promotion on quality use of medicines. Hans Löfgren and Evan Doran describe developments in Australia’s regulation of prescription drug marketing and promotion and show that the pharmaceutical industry has proved less capable of shaping the regulation of promotion than other areas of pharmaceutical policy.
ER  -